Trial intelligence / Profile preview

Observational follow-up of adolescent MenACWY booster responses after preschool MenC priming

2016-002381-31Phase 4Completed

Sponsor
UK Health Security Agency
Start
Jul 2016
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, open-label trial in meningococcal disease comparing Menveo follow-up cohort with Nimenrix follow-up cohort (2 cohorts). Started Jul 2016; status: completed.

02

Drugs

meningococcal A conjugate vaccineMeningococcal polysaccharide vaccine group W-135
03

Conditions

meningococcal disease

Beyond the preview

Go deeper on 2016-002381-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-002381-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call